Indolo substituted piperidine compound as estrogen receptor degrading agent
AssigneesLuoxin Pharmaceutical (Shanghai) Co., Ltd., Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
InventorsJianyu LU, Charles Z. DING, Xu ZENG, Huijun HE, Shuhui CHEN, Lihong HU, Jiaqiang DONG, Tie-Lin WANG
Life of this patent
Estimating the term…
Abstract
Disclosed in the present invention is a type of indole substituted piperidine compounds as an estrogen receptor degrading agent. Specifically disclosed are a compound as shown in formula (I), a pharmaceutically acceptable salt, hydrate or prodrug thereof, a preparation method therefor, a pharmaceutical composition thereof, and a use thereof as an estrogen receptor degrading agent in the treatment of estrogen receptor positive breast cancers.
Claims4
A compound of formula (I), a pharmaceutically acceptable salt, a hydrate or a prodrug thereof,
Dependencies are inferred from the claim text.